Sigurdardottir, Valgerdur <br/><br/>
Repeated switches between reference product etanercept and biosimilar do not affect disease activity or retention rate of etanercept over 24 months - a cohort study with historical controls.  [electronic resource] 

 -  Joint bone spine  07 2019 
 - 529-530 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1778-7254 
<br/><br/><label>Standard No.: </label>10.1016/j.jbspin.2018.12.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biosimilar Pharmaceuticals<br/>Cohort Studies<br/>Etanercept<br/>Humans<br/>Rheumatologists